Cryo-Cell International, Inc. (CCEL) Balance Sheet

NYSE American: CCELAssets, liabilities, debt and equity over 10 years.

CCEL balance sheet, FY2025

November 30, 2025 · U.S. dollars

$61.7M assets = $80.3M liabilities + −$18.6M equity

What it owns$61.7MCash & ST investments: $3.3M (5.3%)Receivables: $6.8M (11.1%)Receivables $6.8MInventory: $408,794 (0.7%)Other current: $1.2M (2.0%)PP&E: $21.9M (35.4%)PP&E$21.9M · 35%Goodwill & intangibles: $2.8M (4.5%)Other non-current: $25.3M (41.0%)Other non-current$25.3M · 41%=How it is financed$80.3MCurrent liabilities: $19.8M (24.6%)Current liabilities$19.8M · 25%Long-term debt: $8.2M (10.2%)Long-term debt $8.2MOther LT liabilities: $52.4M (65.2%)Other LT liabilities$52.4M · 65%

Liabilities exceed assets: shareholders’ equity is negative (−$18.6M).

Both columns are drawn to the same scale: what CCEL owns equals what it owes plus shareholders’ equity. Hover a block for its value.

CCEL financial health

Current ratio0.59
Tight · current assets cover current liabilities 0.59×
Equity / assets−30.1%
Thin equity · of assets funded by shareholders
Cash / debt28.5%
Low cash cover · cash & short-term investments vs total debt
Goodwill & intangibles4.5%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal FY2025.

CCEL balance sheet trends, FY2016–FY2025

Cryo-Cell International, Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$19.5MFY2016$61.7MFY2025+13.6%/yr
Total liabilities$35.0MFY2016$80.3MFY2025+9.7%/yr
Shareholders’ equity−$15.4MFY2016−$18.6MFY2025—
Cash & short-term investments$4.1MFY2016$3.3MFY2025−2.5%/yr
Total debt$9.8MFY2016$11.6MFY2025+1.8%/yr
Net cash (debt)−$5.7MFY2016−$8.3MFY2025−$2.6M
Working capital−$4.1MFY2016−$8.0MFY2025−$3.9M
Book value per share−$1.90FY2016−$2.31FY2025—
Current ratio0.69FY20160.59FY2025−0.09
Shares outstanding8.1MFY20168.1MFY2025−0.1%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

CCEL assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

CCEL liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

CCEL debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

CCEL balance sheet

Cryo-Cell International, Inc. annual balance sheet
FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Assets
Cash & short-term investments$3.3M$3.5M$980,250$1.7M$8.3M$10.4M$7.4M$6.9M$6.7M$4.1M
Cash & equivalents$319,031$560,960$406,067$1.7M$8.3M$10.4M$6.5M$6.0M$6.3M$3.5M
Short-term investments$3.0M$2.9M$574,183$17,620$75,412$88,476$904,053$875,689$439,322$624,223
Receivables$6.8M$7.3M$6.6M$6.0M$5.3M$6.3M$6.1M$5.9M$5.1M$4.1M
Inventory$408,794$657,703$768,877$851,230$921,213$927,318$1.1M$16.0M$314,566$361,142
Other current assets$1.2M$1.1M$1.1M$993,436$1.3M$856,323$760,657$716,280$578,288$473,949
Total current assets$11.8M$12.6M$9.5M$9.6M$15.8M$18.6M$15.4M$29.5M$12.7M$9.0M
Property, plant & equipment (net)$21.9M$22.7M$22.0M$14.2M$4.1M$1.9M$1.8M$1.5M$882,382$979,463
Goodwill & intangible assets$2.8M$2.9M$2.9M$17.1M$18.2M$3.5M$3.2M$3.3M$226,418$261,000
Long-term investments$0$0$308,000$308,000$308,000$308,000$308,000$308,000$0$0
Other non-current assets$25.3M$26.6M$26.5M$23.7M$22.3M$21.9M$22.2M$7.8M$10.1M$9.3M
Total assets$61.7M$64.7M$61.2M$64.9M$60.7M$46.2M$42.9M$42.4M$23.9M$19.5M
Liabilities
Accounts payable$2.9M$1.9M$3.2M$1.6M$1.5M$957,390$1.4M$1.3M$1.9M$1.5M
Short-term debt$2.9M$4.1M$1.6M$2.7M$2.2M$3.4M$3.1M$3.1M$2.0M$2.0M
Deferred revenue$9.7M$9.8M$9.7M$9.6M$9.4M$9.2M$8.9M$8.4M$7.4M$7.1M
Total current liabilities$19.8M$21.6M$20.9M$19.5M$21.1M$16.4M$15.4M$15.4M$13.9M$13.1M
Long-term debt$8.2M$8.3M$8.4M$8.6M$0$2.8M$5.9M$0$0$0
Lease obligations$904,849$933,387$1.1M$610,989$923,056$299,202—$0$0$0
Other long-term liabilities$52.4M$48.0M$43.0M$38.4M$35.4M$29.6M$28.6M$35.9M$22.5M$21.8M
Total liabilities$80.3M$77.9M$72.3M$66.4M$56.5M$48.9M$49.8M$51.3M$36.4M$35.0M
Shareholders' equity
Common stock & paid-in capital$148,771$148,696$148,492$148,480$146,658$136,336$135,989$135,964$128,995$125,044
Retained earnings (deficit)−$38.4M−$32.8M−$31.2M−$21.6M−$16.7M−$18.8M−$22.4M−$25.3M−$24.5M−$26.8M
Treasury stock—————−$20.6M−$20.6M−$19.6M−$111.8M−$33.9M
Accumulated other comprehensive income———————$340,984$40,865$34,408
Minority interest———————$0$0$0
Total shareholders' equity−$18.6M−$13.2M−$11.0M−$1.5M$4.2M−$2.7M−$7.0M−$8.9M−$12.5M−$15.4M
Key figures
Total debt$11.6M$12.9M$10.9M$11.6M$2.8M$6.2M$9.0M$12.9M$7.3M$9.8M
Net cash (debt)−$8.3M−$9.4M−$9.9M−$9.9M$5.5M$4.2M−$1.5M−$6.0M−$576,707−$5.7M
Working capital−$8.0M−$9.0M−$11.4M−$9.9M−$5.3M$2.1M−$41,818$14.1M−$1.2M−$4.1M
Tangible book value−$21.4M−$16.1M−$14.0M−$18.6M−$14.0M−$6.1M−$10.1M−$12.2M−$12.7M−$15.7M
Book value per share−$2.31−$1.61−$1.32−$0.18$0.50−$0.33−$0.83−$1.19−$1.63−$1.90
Shares outstanding8.1M8.2M8.3M8.5M8.4M8.1M8.4M7.5M7.7M8.1M
Current ratio0.590.580.450.490.751.131.001.910.910.69
Quick ratio0.510.500.360.400.641.020.880.830.850.62
Debt / equity————0.67—————
Equity / assets−30.1%−20.4%−18.0%−2.3%6.9%−5.8%−16.2%−21.0%−52.3%−78.9%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 27, 2026); data from EODHD.

CCEL financial position

At the end of fiscal 2025 (November 30, 2025), Cryo-Cell International had total assets of $61.7 million (down 4.6% from a year earlier), total liabilities of $80.3 million and shareholders' equity of -$18.6 million. It held $3.3 million in cash and short-term investments against $11.6 million of debt, net debt of $8.3 million. Its current ratio was 0.59. In the latest quarter (ended August 31, 2026) total assets were $62.3 million and equity -$16.4 million.

Related: CCEL income statement, CCEL cash flow statement, CCEL key metrics. See the CCEL stock overview for the latest quote and news.

CCEL balance sheet FAQ

What are Cryo-Cell International's total assets?

Cryo-Cell International reported total assets of $61.7 million at the end of fiscal 2025 (November 30, 2025), compared with $64.7 million a year earlier.

How much debt does Cryo-Cell International have?

Cryo-Cell International had $11.6 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was —.

How much cash does Cryo-Cell International have?

Cryo-Cell International held $3.3 million in cash and short-term investments at the end of fiscal 2025; with $11.6 million of debt that is net debt of $8.3 million.

What is Cryo-Cell International's book value?

Cryo-Cell International's shareholders' equity (book value) was -$18.6 million at the end of fiscal 2025, or −$2.31 per share.

What is Cryo-Cell International's current ratio?

Cryo-Cell International had current assets of $11.8 million and current liabilities of $19.8 million, a current ratio of 0.59 (current liabilities exceed current assets).

How much goodwill does Cryo-Cell International have?

Cryo-Cell International carried $2.8 million of goodwill and intangible assets, 4.5% of total assets, at the end of fiscal 2025.

Medical Care Facilities: balance sheet